Sufentanil
Dsuvia, Sufenta, Dzuveo, Zalviso (sufentanil) is a small molecule pharmaceutical. Sufentanil was first approved as Dsuvia on 1984-05-04. It is used to treat pain in the USA. It has been approved in Europe to treat pain and postoperative pain. The pharmaceutical is active against mu-type opioid receptor. Sufentanil citrate's patents are valid until 2031-07-29 (FDA).
| Trade Name | Dzuveo, Zalviso |
|---|---|
| Common Name | Sufentanil |
| Indication | pain, postoperative pain |
| Drug Class | Narcotic analgesics (fentanyl derivatives) |
